Metso Corporation Unsponsored ADR (ADR)
General ticker "OUKPY" information:
- Sector: Industrials
- Industry: Agricultural - Machinery
- Capitalization: $19.1B (TTM average)
Metso Corporation Unsponsored ADR (ADR) follows the US Stock Market performance with the rate: 55.3%.
Estimated limits based on current volatility of 1.4%: low 9.14$, high 9.40$
Factors to consider:
- Company pays dividends (semi-annually): last record date 2025-10-24, amount 0.03$ (Y0.64%)
- Current price 66.3% above estimated high
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.96$, 5.23$]
- 2025-12-31 to 2026-12-31 estimated range: [3.24$, 5.60$]
Financial Metrics affecting the OUKPY estimates:
- Positive: with PPE of 14.3 at the end of fiscal year the price was very low
- Positive: 7.54 < Operating profit margin, % of 14.95
- Negative: 0 < Industry inventory ratio change (median), % of 0.11
- Positive: 19.35 < Shareholder equity ratio, % of 37.08 <= 42.53
- Positive: 5.42 < Industry operating cash flow per share per price (median), % of 6.42
- Positive: Interest expense per share per price, % of 1.10 <= 3.31
- Positive: 1.77 < Return on assets ratio (scaled to [-100,100]) of 4.48
- Negative: Industry operating profit margin (median), % of 1.78 <= 2.95
- Negative: Operating cash flow per share per price, % of 4.33 <= 6.63
- Negative: Inventory ratio change, % of 1.52 > 0.82
Short-term OUKPY quotes
Long-term OUKPY plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | €5,295.00MM | €5,390.00MM | €4,863.00MM |
| Operating Expenses | €4,791.00MM | €4,585.00MM | €4,136.00MM |
| Operating Income | €504.00MM | €805.00MM | €727.00MM |
| Non-Operating Income | €-63.00MM | €-81.00MM | €-79.00MM |
| Interest Expense | €44.00MM | €101.00MM | €84.00MM |
| R&D Expense | €64.00MM | €66.00MM | €103.00MM |
| Income(Loss) | €441.00MM | €724.00MM | €648.00MM |
| Taxes | €112.00MM | €187.00MM | €162.00MM |
| Profit(Loss)* | €301.00MM | €543.00MM | €329.00MM |
| Stockholders Equity | €2,342.00MM | €2,608.00MM | €2,601.00MM |
| Inventory | €1,846.00MM | €1,951.00MM | €1,900.00MM |
| Assets | €6,754.00MM | €7,156.00MM | €7,015.00MM |
| Operating Cash Flow | €127.00MM | €302.00MM | €332.00MM |
| Capital expenditure | €114.00MM | €170.00MM | €188.00MM |
| Investing Cash Flow | €-132.00MM | €-178.00MM | €-224.00MM |
| Financing Cash Flow | €127.00MM | €-77.00MM | €-315.00MM |
| Earnings Per Share** | €0.18 | €0.33 | €0.19 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.